[RDHL] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
22-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -55.07%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 64,359 6,291 8,360 4,007 101 3 7,014 44.64%
PBT -76,173 -42,304 -38,820 -45,544 -29,370 -21,090 -10,711 38.63%
Tax 12,844 1,330 727 6,285 1,273 900 222 96.54%
NP -89,017 -43,634 -38,820 -45,544 -29,370 -21,090 -10,711 42.27%
Tax Rate - - - - - - - -
Total Cost 153,376 49,925 47,180 49,551 29,471 21,093 17,725 43.23%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -138.31 -693.59 -464.35 -1,136.61 -29,079.21 -703,000.00 -152.71 -1.63%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -97.75 -58.78 -68.00 -104.00 -94.96 -76.13 -49.47 12.00%
EPS Diluted -97.75 -58.78 -68.00 -104.00 -92.00 -75.51 -49.12 12.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.